TITLE

Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy

AUTHOR(S)
Di Giuseppe, G; Abbate, R; Liguori, G; Albano, L; Angelillo, I F
PUB. DATE
July 2008
SOURCE
British Journal of Cancer;7/22/2008, Vol. 99 Issue 2, p225
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This study assesses knowledge, attitudes, and behavioural intention towards human papillomavirus (HPV) infection and vaccination in a random sample of 1348 adolescents and young women aged 14–24 years in Italy. A self-administered anonymous questionnaire covered demographics; knowledge about HPV infection, cervical cancer, and HPV vaccine; the perceived risk for contracting HPV infection and/or for developing cervical cancer, the perceived benefits of a vaccination to prevent cervical cancer, and willingness to receive an HPV vaccine. Only 23.3% have heard that HPV is an infection of the genital mucosa and about cervical cancer. Those older, with at least one parent who is a health care professional, with personal, familiar, or friendly history of cervical cancer, and having underwent a health checkup in the last year with information about HPV vaccination were significantly more knowledgeable. Risk perception scores (range: 1–10) of contracting HPV infection and of developing cervical cancer were 5.8 and 6.5. Older age, not having a parent who is a health care professional, having had a personal, familiar, or friendly history of cervical cancer, and need of additional information were predictors of the perceived susceptibility of developing cervical cancer. The vast majority professed intent to receive an HPV vaccine and the significant predictors were having at least one parent who is a health care professional, a high perceived risk of contracting HPV infection and of developing cervical cancer, and a high belief towards the utility of a vaccination for preventing cervical cancer. Knowledge about HPV infection and cervical cancer should be improved with more attention to the benefit of HPV vaccination.British Journal of Cancer (2008) 99, 225–229. doi:10.1038/sj.bjc.6604454 www.bjcancer.com
ACCESSION #
33163018

 

Related Articles

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years. Wheeler, Cosette M.; Kjaer, Susanne K.; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Perez, Gonzalo; Brown, Darron R.; Koutsky, Laura A.; Tay, Eng Hseon; García, Patricia; Ault, Kevin A.; Garland, Suzanne M.; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W. K.; Ferris, Daron G.; Paavonen, Jorma; Steben, Marc; Bosch, F. Xavier; Dillner, Joakim // Journal of Infectious Diseases;4/1/2009, Vol. 199 Issue 7, p936 

    Background. We evaluated the impact of a quadrivalent human papillomavirus (HPV) vaccine on infection and cervical disease related to 10 nonvaccine HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, and 59) associated with >20% of cervical cancers. The population evaluated included HPV-naive women...

  • Research eyes HPV vaccine effectiveness.  // Contraceptive Technology Update;Sep2007, Vol. 28 Issue 9, p103 

    EXECUTIVE SUMMARY Results from a meta-analysis study of Gardasil, the cervical cancer vaccine, indicate the shot is nearly 100% effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer. • Scientists now have evidence that HPV causes...

  • Screening for HPV persistence and cervical cancer risk.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p164 

    The article reports on the result of the study which revealed that women over the age of 30 who are positive for human papillomavirus (HPV) should be re-tested two years after as part of their cervical cancer screening.

  • Association of Posttherapy Positron Emission Tomography With Tumor Response and Survival in Cervical Carcinoma. Schwarz, Julie K.; Siegel, Barry A.; Dehdashti, Farrokh; Grigsby, Perry W. // JAMA: Journal of the American Medical Association;11/21/2007, Vol. 298 Issue 19, p2289 

    This article reports on the findings of a study that examine the association of posttherapy positron emission tomography to tumor response and survival rates in women with cervical cancer. The development of the human papilloma virus (HPV) vaccine to prevent some cases of cervical cancer does...

  • AWARENESS REGARDING HUMAN PAPILLOMA VIRUS AND ITS VACCINE AMONG FINAL YEAR MBBS STUDENTS. Sanghavi, Mithun M. // National Journal of Community Medicine;Apr-Jun2014, Vol. 5 Issue 2, p169 

    Background and Objectives: Human papilloma virus is the major cause of cervical cancer in women and HPV vaccination is emerging as the most effective option. As the medical students will serve the community in the future, awareness regarding HPV vaccine is very necessary among them. The current...

  • Cervical audit reveals success and failure. Meylan, Greg // New Zealand Doctor;12/1/2004, p5 

    Reports on the results of an audit conducted to the National Cervical Screening Programme (NCSP) in New Zealand in 2004. Recommendations for the improvement of NCSP; Comparison of the services provided by the programme between Maori women and non-Maori women with cervical cancer; Improvements...

  • Detection of human papillomavirus DNA in urine. A review of the literature. Vorsters, A.; Micalessi, I.; Bilcke, J.; Ieven, M.; Bogers, J.; Damme, P. // European Journal of Clinical Microbiology & Infectious Diseases;May2012, Vol. 31 Issue 5, p627 

    The detection of human papillomavirus (HPV) DNA in urine, a specimen easily obtained by a non-invasive self-sampling method, has been the subject of a considerable number of studies. This review provides an overview of 41 published studies; assesses how different methods and settings may...

  • HPV Vaccine Acceptability in a Rural Southern Area. Fazekas, Karah I.; Brewer, Noel T.; Smith, Jennifer S. // Journal of Women's Health (15409996);May2008, Vol. 17 Issue 4, p539 

    Background: Although cervical cancer rates in the United States are highest in Southern and rural areas, research on human papillomavirus (HPV) vaccine acceptability has focused on other geographic areas. Methods: To address this gap, we surveyed women from a rural area in North Carolina with...

  • Response to The HPV Vaccination Campaign: A Project of Moral Regulation in an Era of Biopolitics. MACDONALD, LIANE; DEEKS, SHELLEY; DOYLE, CAROLYN // Canadian Journal of Sociology;Fall2010, Vol. 35 Issue 4, p627 

    In this article the authors discuss the Canadian public health campaign regarding the human papillomavirus (HPV) vaccination used for the prevention of cervical cancer. They argue that a voluntary program in schools could provide access to the HPV vaccination for low-income and Aboriginal women,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics